Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post by Stanford Radiation Oncology on X, adding:
“Breakthrough research happening because of NIH funding. We need to keep it flowing so there can be even more!”
Quoting Stanford Radiation Oncology‘s post:
“New study in Cancer Discovery led by Anusha Kalbasi and UCLA Health : A ‘triple-threat’ combo of radiation + immunotherapy before surgery helps the body destroy ‘invisible’ sarcoma cells. Congratulations to Dr. Kalbasi and the entire team on this milestone! Full story.”
Other articles about Immunotherapy on OncoDaily.